Snap-25 Cleavage
Snap-25 Cleavage - Related Videos
08:04
Evaluating the Accuracy of Snap Judgments
0 Views •
2023
Source: Diego Reinero & Jay Van Bavel—New York University Social psychologists have long been interested in the way people form impressions of others. Much of this work has focused on the errors people make in judging others, such as the exaggerated influence of central traits (such as "warm" and "cold"), the insufficient weight given to the context in which others' behavior takes place, and the tendency for people to make judgments that conform to their initial expectations about another.
07:33
Physical Properties Of Minerals I: Crystals and Cleavage
0 Views •
2023
Source: Laboratory of Alan Lester - University of Colorado Boulder The physical properties of minerals comprise various measurable and discernible attributes, including color, streak, magnetic properties, hardness, crystal growth form, and crystal cleavage. Each of these properties are mineral-specific, and they are fundamentally related to a particular mineral’s chemical make-up and atomic structure. This experiment examines two properties that stem primarily from symmetric repetition of...
04:36
A Snap Chip Technology for a Cross-Reactivity-Free Multiplexed Sandwich Immunoassay
0 Views •
2025
The video showcases the implementation of snap chip technology for cross-reactivity-free multiplexed sandwich immunoassays. The simple action of snapping two microarray slides, each containing different reagents, ensures reagent transfer without cross-contamination and helps to detect multiple proteins using sandwich immunoassay.
10:44
Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
0 Views •
Cited by 3 •
2017
We demonstrate a snap chip technology for performing cross-reactivity-free multiplexed sandwich immunoassays by simply snapping two slides. A snap apparatus is used for reliably transferring reagents from microarray-to-microarray. The snap chip can be used for any biochemical reactions requiring colocalization of different reagents without cross-contamination.
02:42
A Fluorogenic Peptide Cleavage Assay to Screen the Proteolytic Activity of Proteases
0 Views •
2025
This video demonstrates an assay to screen for the proteolytic activity of proteases using fluorogenic peptides. The protease recognizes its cleavage site on the peptide, cleaving it and separating the quencher from the fluorophore, enabling its fluorescence emission. The fluorescence signal is detected and analyzed to check for the cleavage efficiency of different peptide variants.
FAQs
The light chain’s zinc-dependent endopeptidase activity provides the direct molecular event monitored when evaluating botulinum neurotoxin. Its recognition and cutting of SNAP-25 connect enzymatic action to loss of a protein required for regulated neurotransmitter release. Measuring this cleavage therefore links toxin exposure with a defined pharmacological mechanism rather than relying only on the final physiological effect.
SNAP-25 cleavage interrupts the protein contribution required for SNARE-complex assembly. Without that assembly step, synaptic vesicles cannot fuse normally with the presynaptic membrane, so regulated neurotransmitter release is blocked. This sequence explains why cleavage is more than a biochemical observation: it directly connects botulinum neurotoxin’s enzymatic action with impaired neuronal communication.
Muscle paralysis represents a downstream physiological outcome, whereas SNAP-25 cleavage identifies a molecular event caused by botulinum neurotoxin activity. This distinction helps investigators examine toxin mechanism and potency at the level of the affected release machinery. It also supports interpretation of therapeutic action and safety by connecting observed effects to the specific proteolytic process involved.
Detecting SNAP-25 cleavage provides a molecular readout for evaluating botulinum neurotoxin activity. Pharmacological assays can use this readout to investigate toxin potency and mechanism, while also supporting studies of therapeutic action and safety. Because the cleavage event lies between enzymatic activity and blocked neurotransmitter release, it helps relate biochemical measurements to the toxin’s functional consequences.
At the neuromuscular junction, cleavage indicates that the release machinery needed for acetylcholine secretion has been disrupted. The resulting reduction in acetylcholine release explains the development of temporary muscle paralysis associated with botulinum neurotoxin activity. Thus, the cleavage marker connects a presynaptic molecular change with the pharmacological effect observed in muscle.
The presence of cleavage demonstrates that the toxin has acted on its intended presynaptic protein target, while its relationship to blocked neurotransmitter release helps explain the resulting pharmacological effect. Using this molecular marker alongside functional outcomes can support evaluation of therapeutic action and safety. It provides mechanistic context for understanding temporary paralysis rather than treating it as an unexplained endpoint.